RY

163.4

+1.03%↑

TD

94.62

+1.38%↑

BMO

137.05

+1.2%↑

CM

96.02

+1.35%↑

BNS

70.13

+1.23%↑

RY

163.4

+1.03%↑

TD

94.62

+1.38%↑

BMO

137.05

+1.2%↑

CM

96.02

+1.35%↑

BNS

70.13

+1.23%↑

RY

163.4

+1.03%↑

TD

94.62

+1.38%↑

BMO

137.05

+1.2%↑

CM

96.02

+1.35%↑

BNS

70.13

+1.23%↑

RY

163.4

+1.03%↑

TD

94.62

+1.38%↑

BMO

137.05

+1.2%↑

CM

96.02

+1.35%↑

BNS

70.13

+1.23%↑

RY

163.4

+1.03%↑

TD

94.62

+1.38%↑

BMO

137.05

+1.2%↑

CM

96.02

+1.35%↑

BNS

70.13

+1.23%↑

Search

CNO Financial Group Inc

Отворен

СекторФинансови

41.21 0.76

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

41.02

Максимум

41.74

Ключови измерители

By Trading Economics

Приходи

70M

93M

Продажби

-46M

1.1B

P/E

Средно за сектора

17.171

55.155

EPS

1.47

Дивидентна доходност

1.69

Марж на печалбата

8.127

Служители

3,300

EBITDA

-8.3M

165M

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+15.31% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

1.69%

4.95%

Следващи печалби

27.04.2026 г.

Следваща дата на дивидент

23.06.2026 г.

Следваща дата на екс-дивидент

9.06.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-361M

3.8B

Предишно отваряне

40.45

Предишно затваряне

41.21

Настроения в новините

By Acuity

54%

46%

353 / 441 Класиране в Finance

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

CNO Financial Group Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

31.03.2026 г., 23:31 ч. UTC

Горещи акции

Stocks to Watch: Nike, RH, NCino

31.03.2026 г., 22:35 ч. UTC

Печалби

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1.04.2026 г., 00:00 ч. UTC

Придобивния, сливания и поглъщания

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31.03.2026 г., 23:50 ч. UTC

Придобивния, сливания и поглъщания

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31.03.2026 г., 23:43 ч. UTC

Пазарно говорене

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31.03.2026 г., 23:33 ч. UTC

Пазарно говорене
Значими събития в новините

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31.03.2026 г., 23:21 ч. UTC

Печалби

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31.03.2026 г., 23:14 ч. UTC

Пазарно говорене
Печалби

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31.03.2026 г., 23:12 ч. UTC

Пазарно говорене

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31.03.2026 г., 22:36 ч. UTC

Печалби

China Vanke 2025 Loss Widens >000002.SZ

31.03.2026 г., 22:36 ч. UTC

Печалби

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31.03.2026 г., 22:36 ч. UTC

Печалби

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31.03.2026 г., 22:36 ч. UTC

Печалби

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31.03.2026 г., 22:36 ч. UTC

Печалби

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31.03.2026 г., 21:46 ч. UTC

Придобивния, сливания и поглъщания

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31.03.2026 г., 21:36 ч. UTC

Пазарно говорене

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31.03.2026 г., 21:35 ч. UTC

Печалби

Nike Expects China Sales Down 20% in 4Q, CFO Says

31.03.2026 г., 21:35 ч. UTC

Печалби

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31.03.2026 г., 21:35 ч. UTC

Печалби

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31.03.2026 г., 21:33 ч. UTC

Придобивния, сливания и поглъщания

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31.03.2026 г., 21:33 ч. UTC

Печалби

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31.03.2026 г., 21:32 ч. UTC

Печалби

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31.03.2026 г., 21:28 ч. UTC

Печалби

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31.03.2026 г., 21:26 ч. UTC

Печалби

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31.03.2026 г., 21:25 ч. UTC

Печалби

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31.03.2026 г., 21:24 ч. UTC

Пазарно говорене
Печалби

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31.03.2026 г., 21:22 ч. UTC

Печалби

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31.03.2026 г., 21:22 ч. UTC

Печалби

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31.03.2026 г., 21:21 ч. UTC

Печалби

Nike's Digital Channel Still Too Promotional, CFO Says

31.03.2026 г., 21:20 ч. UTC

Печалби

Nike CEO: Converse Remains Important to Portfolio

Сравнение с други в отрасъла

Ценова промяна

CNO Financial Group Inc Прогноза

Ценова цел

By TipRanks

15.31% нагоре

12-месечна прогноза

Среден 46.33 USD  15.31%

Висок 50 USD

Нисък 43 USD

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за CNO Financial Group Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

3 ratings

1

Купи

1

Задържане

1

Продай

Техническа оценка

By Trading Central

37.56 / 38.01Подкрепа & съпротива

Краткосрочен план

Very Strong Bearish Evidence

Средносрочен план

Strong Bearish Evidence

Дългосрочен план

Bullish Evidence

Настроение

By Acuity

353 / 441 Класиране в Финансови

Настроения в новините

Мечи доказателства

Волатилност

Над средното

Обем новини (RCV)

Над средното

Финанси

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно CNO Financial Group Inc

CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, insurance products, and financial services for senior and middle-income markets in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individuals through phone, online, mail, and face-to-face. The company also focuses on sale of voluntary benefit life and health insurance products for businesses, associations, and other membership groups by interacting with customers at their place of employment. In addition, it provides fixed indexed annuities; fixed interest annuities, including fixed rate single and flexible premium deferred annuities; single premium immediate annuities; supplemental health products, such as specified disease, accident, and hospital indemnity products; and long-term care plans primarily to retirees and older self-employed individuals in the middle-income market. Further, the company offers universal life and other interest-sensitive life products; and traditional life policies that include whole life, graded benefit life, term life, and single premium whole life products, as well as graded benefit life insurance products. It markets its products under the Bankers Life, Washington National, and Colonial Penn brand names. The company was founded in 1979 and is headquartered in Carmel, Indiana.
help-icon Live chat